Igor Stzepourginski

Company: Eligo Bioscience

Job title: Head of Preclinical Operations

Seminars:

A Novel Therapeutic Approach for the Elimination of Harmful Bacteria From the Microbiome 1:45 pm

Learn the development of Eligobiotics(r): a new class of phage-derived antimicrobials with unparalleled specificity EB003: an Eligobiotic(r) for the treatment of Shiga toxin-producing E.coli Eligobiotics(r) as novel Gene Therapy products allowing precise intervention on the microbiomeRead more

day: Day 2 - Track A Evening